封面
市場調查報告書
商品編碼
1288666

全球可吸收抗菌包膜市場研究報告 - 行業分析、規模、佔有率、成長、趨勢和2023年至2030年預測

Global Absorbable Antibacterial Envelope Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: | 出版商: Value Market Research | 英文 139 Pages | 商品交期: 最快1-2個工作天內

價格

到2030年,全球對可吸收抗菌包膜的需求將從2022年的35.94百萬美元達到近71.82百萬美元的市場規模,在2023-2030年的研究期間,年復合成長率為9.04%。

可吸收的抗菌封套是一種醫療設備,可以減少接受心臟植入手術的病人的感染風險,如心臟起搏器或除顫器的植入。該設備由一種生物可吸收的聚合物基質製成,其中含有抗生素,如米諾環素和利福平,在植入後的幾週內逐漸釋放。可吸收抗菌包膜在手術時放置在植入式設備周圍,旨在在設備與周圍組織之間提供物理屏障。包膜內的抗生素會隨著時間的推移緩慢釋放,有助於防止植入物部位的感染。該設備通常用於發生感染的高風險患者,例如以前在心臟植入部位感染過的患者或患有使他們更容易感染的潛在疾病的患者。可吸收抗菌包膜是心臟植入領域的重要進步,因為植入部位的感染可能很嚴重,可能危及生命。使用該封套可以幫助減少這些感染的發生率,從而改善病人的治療效果,降低醫療費用。

市場動態:

心血管疾病的發病率越來越高,加上人口老齡化,正在推動對心臟植入手術的需求。這推動了對可吸收抗菌包膜的需求,這種包膜用於防止植入部位的感染。心臟植入部位的感染可能是嚴重的,並威脅到生命。事實證明,使用可吸收抗菌包膜可以減少這些感染的發生率,從而促使對這些設備的需求增加。開發更先進、更有效的可吸收抗菌包膜在預防感染方面更有效,而且比早期版本的副作用更少。可吸收抗菌包膜的好處,如減少感染風險和縮短住院時間,在病人和醫療機構中越來越為人所知。這正在推動對這些設備的需求。世界各國政府都在鼓勵採用抗菌醫療設備,包括可吸收抗菌封套,以減少感染的發生率和改善病人的治療效果。

該研究報告涵蓋了波特的五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清楚地瞭解行業結構,並在全球範圍內評估競爭吸引力。此外,這些工具還對全球可吸收抗菌包膜市場的每個細分市場進行了包容性評估。可吸收抗菌信膜行業的發展和趨勢為本研究提供了整體方法。

區域分析:

本節涵蓋了區域前景,強調了北美、歐洲、亞太、拉丁美洲以及中東和非洲地區對可吸收抗菌包膜市場的當前和未來需求。此外,該報告重點關注所有突出地區的各個應用部門的需求、估計和預測。

該研究報告還涵蓋了市場中主要參與者的全面概況和對全球競爭格局的深入看法。可吸收抗菌包膜市場的主要參與者包括Medtronic plc和Aziyo Biologics, Inc。這一部分包括對競爭格局的整體看法,其中包括各種戰略發展,如主要的合併和收購,未來的能力,夥伴關係,財務概況,合作,新產品的開發,新產品的推出,以及其他發展。

目錄

第1章:前言

  • 報告描述
    • 目的
    • 目標受眾
    • 獨特的銷售主張(USP)和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法

第二章:執行摘要

  • 市場的亮點
  • 全球市場簡介

第三章:可吸收抗菌包膜- 行業分析

  • 簡介- 市場動態
  • 市場驅動力
  • 市場限制因素
  • 機會
  • 行業趨勢
  • 波特的五力分析
  • 市場吸引力分析
    • 市場吸引力分析:按應用
    • 市場吸引力分析:按終端用戶
    • 市場吸引力分析:按地區

第四章:價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商名單
    • 關鍵原料的價格趨勢
  • 潛在買家名單
  • 行銷管道
    • 直接行銷
    • 間接行銷
    • 行銷管道的發展趨勢

第五章:Covid-19疫情的影響分析

  • Covid-19疫情的影響分析
    • 對生產的直接影響
    • 供應鍊和市場的破壞
    • 對企業和金融市場的財務影響
  • 按生產、進口、出口和需求分析COVID-19的影響
  • 市場:COVID-19之前和之後
  • 冠狀病毒(COVID-19)疫情的估計影響
  • COVID-19:微觀和宏觀因素分析

第六章:全球可吸收抗菌包膜市場分析:按應用分類

  • 概述:按應用分類
  • 歷史和預測數據
  • 分析:按應用分類
  • 心臟再同步化治療除顫器(CRT-D)
  • 植入式心律轉復除顫器(ICD)
  • 心臟再同步化治療起搏器(CRT-P)。

第7章:全球可吸收抗菌包膜市場分析:按終端用戶分類

  • 按終端用戶概述
  • 歷史和預測數據
  • 按終端用戶分析
  • 醫院
  • 非住院手術中心(ASCs)
  • 其他

第八章:全球可吸收抗菌包膜市場分析:按地域分類

  • 區域展望
  • 簡介
  • 北美洲銷售分析
    • 概述,歷史和預測的銷售分析
    • 北美地區分部銷售分析
    • 北美地區國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概況、歷史和預測的銷售分析
    • 歐洲分部銷售分析
    • 歐洲國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概況、歷史和預測的銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳大利亞銷售分析
    • 亞太其他地區銷售分析
  • 拉美地區銷售分析
    • 概況、歷史和預測的銷售分析
    • 拉美地區分部銷售分析
    • 拉美地區國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉美其他地區銷售分析
  • 中東和非洲銷售分析
    • 概況、歷史和預測銷售分析
    • 中東和非洲地區分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第九章:可吸收抗菌包膜企業的競爭格局

  • 可吸收的抗菌包膜市場競爭
  • 夥伴關係/合作/協議
  • 合併和收購
  • 新產品發布
  • 其他方面的發展

第十章:公司簡介

  • 頂級公司的市場佔有率分析
  • 市場集中度
  • Medtronic plc
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展
  • Aziyo Biologics Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 近期發展情況

注意- 在公司簡介中,財務細節和最近的發展情況取決於可用性,可能不包括私人公司在內。

Product Code: VMR112110509

The global demand for Absorbable Antibacterial Envelope Market is presumed to reach the market size of nearly USD 71.82 MN by 2030 from USD 35.94 MN in 2022 with a CAGR of 9.04% under the study period 2023-2030.

An absorbable antibacterial envelope is a medical device that reduces the risk of infections in patients undergoing cardiac implant procedures, such as pacemakers or defibrillator implantation. The device is made of a bio-absorbable polymer matrix that contains antibiotics, such as minocycline and rifampin, which are released gradually over a period of several weeks after implantation. The Absorbable Antibacterial Envelope is placed around the implantable device at the time of the procedure and is designed to provide a physical barrier between the device and surrounding tissue. The antibiotics within the envelope are released slowly over time, helping to prevent infection at the site of the implant. The device is typically used in patients who are at a high risk of developing infections, such as those who have previously had infections at the site of a cardiac implant or those who have underlying medical conditions that make them more susceptible to infections. The Absorbable Antibacterial Envelope is an important advancement in the field of cardiac implantation, as infections at the site of the implant can be serious and potentially life-threatening. The use of the envelope can help to reduce the incidence of these infections, leading to better patient outcomes and reduced healthcare costs.

Market Dynamics:

The growing incidence of cardiovascular disease, coupled with an aging population, is driving the demand for cardiac implant procedures. This is driving the demand for absorbable antibacterial envelopes, which are used to prevent infections at the site of the implant. Infections at the site of cardiac implants can be serious and life-threatening. The use of absorbable antibacterial envelopes has been shown to reduce the incidence of these infections, leading to increased demand for these devices. Development of more advanced and effective absorbable antibacterial envelopes are more effective at preventing infections and have fewer side effects than earlier versions. The benefits of absorbable antibacterial envelopes, such as the reduced risk of infection and shorter hospital stays, are becoming increasingly well-known among patients and healthcare providers. This is driving the demand for these devices. Governments around the world are encouraging the adoption of antibacterial medical devices, including absorbable antibacterial envelopes, to reduce the incidence of infections and improve patient outcomes.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of absorbable antibacterial envelope. The growth and trends of absorbable antibacterial envelope industry provide a holistic approach to this study.

Market Segmentation:

This section of the absorbable antibacterial envelope market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

  • Cardiac Resynchronization Therapy Defibrillators (CRT-D)
  • Implantable Cardioverter Defibrillators (Icd)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P)

By End-User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Others

Regional Analysis:

This section covers the regional outlook, which accentuates current and future demand for the Absorbable Antibacterial Envelope market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the absorbable antibacterial envelope market include Medtronic plc and Aziyo Biologics, Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ABSORBABLE ANTIBACTERIAL ENVELOPE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Application
    • 3.7.2 Market Attractiveness Analysis By End-user
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

  • 5.1. Impact Analysis of Covid-19 Outbreak
    • 5.1.1. Direct Impact on Production
    • 5.1.2. Supply Chain and Market Disruption
    • 5.1.3. Financial Impact on Firms and Financial Markets
  • 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
  • 5.3. Market: Pre V/S Post COVID-19
  • 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
  • 5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 Cardiac Resynchronization Therapy Defibrillators (CRT-D) Historic and Forecast Sales by Regions
  • 6.5 Implantable Cardioverter Defibrillators (ICD) Historic and Forecast Sales by Regions
  • 6.6 Cardiac Resynchronization Therapy Pacemakers (CRT-P) Historic and Forecast Sales by Regions

7 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-user
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-user
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Ambulatory Surgical Centers (ASCs) Historic and Forecast Sales by Regions
  • 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ABSORBABLE ANTIBACTERIAL ENVELOPE MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ABSORBABLE ANTIBACTERIAL ENVELOPE COMPANIES

  • 9.1. Absorbable Antibacterial Envelope Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF ABSORBABLE ANTIBACTERIAL ENVELOPE INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Medtronic plc
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Aziyo Biologics Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  • COVID-19: Micro and Macro Factor Analysis
  • Analysis by Application (USD MN)
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D) Market Sales by Geography (USD MN)
  • Implantable Cardioverter Defibrillators (ICD) Market Sales by Geography (USD MN)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P) Market Sales by Geography (USD MN)
  • Analysis Market by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers (ASCs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Absorbable Antibacterial Envelope Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Absorbable Antibacterial Envelope Report
  • Market Research Process
  • Market Research Methodology
  • Global Absorbable Antibacterial Envelope Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Application
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Application (USD MN)
  • Cardiac Resynchronization Therapy Defibrillators (CRT-D) Market Sales by Geography (USD MN)
  • Implantable Cardioverter Defibrillators (ICD) Market Sales by Geography (USD MN)
  • Cardiac Resynchronization Therapy Pacemakers (CRT-P) Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Hospitals Market Sales by Geography (USD MN)
  • Ambulatory Surgical Centers (ASCs) Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Companies Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.